NO962074D0 - Amfifiliske derivater av guanidin - Google Patents

Amfifiliske derivater av guanidin

Info

Publication number
NO962074D0
NO962074D0 NO962074A NO962074A NO962074D0 NO 962074 D0 NO962074 D0 NO 962074D0 NO 962074 A NO962074 A NO 962074A NO 962074 A NO962074 A NO 962074A NO 962074 D0 NO962074 D0 NO 962074D0
Authority
NO
Norway
Prior art keywords
guanidine
amphiphilic derivatives
amphiphilic
derivatives
Prior art date
Application number
NO962074A
Other languages
English (en)
Other versions
NO962074L (no
Inventor
Timothy D Heath
Igor Solodin
Original Assignee
Megabios Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megabios Corp filed Critical Megabios Corp
Publication of NO962074D0 publication Critical patent/NO962074D0/no
Publication of NO962074L publication Critical patent/NO962074L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO962074A 1993-11-24 1996-05-21 Amfifiliske derivater av guanidin NO962074L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15772793A 1993-11-24 1993-11-24
US24800594A 1994-05-24 1994-05-24
PCT/US1994/013428 WO1995014381A1 (en) 1993-11-24 1994-11-17 Amphiphilic derivatives of guanidine

Publications (2)

Publication Number Publication Date
NO962074D0 true NO962074D0 (no) 1996-05-21
NO962074L NO962074L (no) 1996-07-11

Family

ID=26854424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962074A NO962074L (no) 1993-11-24 1996-05-21 Amfifiliske derivater av guanidin

Country Status (8)

Country Link
EP (1) EP0730405A4 (no)
JP (1) JPH09505808A (no)
KR (1) KR960705771A (no)
AU (1) AU691226B2 (no)
CA (1) CA2176715A1 (no)
NO (1) NO962074L (no)
NZ (1) NZ276975A (no)
WO (1) WO1995014381A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840710A (en) * 1994-12-09 1998-11-24 Genzyme Corporation Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
US6331524B1 (en) 1994-12-09 2001-12-18 Genzyme Corporation Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
US5948767A (en) * 1994-12-09 1999-09-07 Genzyme Corporation Cationic amphiphile/DNA complexes
US5650096A (en) * 1994-12-09 1997-07-22 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5747471A (en) * 1994-12-09 1998-05-05 Genzyme Corporation Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US6383814B1 (en) 1994-12-09 2002-05-07 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5767099A (en) * 1994-12-09 1998-06-16 Genzyme Corporation Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
US5910487A (en) * 1994-12-09 1999-06-08 Genzyme Corporation Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
US5830878A (en) * 1995-06-07 1998-11-03 Megabios Corporation Cationic lipid: DNA complexes for gene targeting
EP0863749A2 (en) 1995-11-30 1998-09-16 Vical Incorporated Complex cationic lipids
SE9504347D0 (sv) * 1995-12-01 1995-12-01 Boerje Sellergren Surface modification technique
EP0779361A3 (en) 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof
ES2154453T3 (es) * 1996-03-01 2001-04-01 Centre Nat Rech Scient Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones.
US5935936A (en) * 1996-06-03 1999-08-10 Genzyme Corporation Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
US5861397A (en) * 1996-10-03 1999-01-19 Vical Incorporated Piperazine based cytofectins
CA2217550A1 (en) * 1996-10-22 1998-04-22 F. Hoffmann-La Roche Ag Cationic lipids for gene therapy
US5925628A (en) * 1997-03-31 1999-07-20 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5912239A (en) * 1997-04-04 1999-06-15 Genzyme Corporation Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
US6235310B1 (en) 1997-04-04 2001-05-22 Valentis, Inc. Methods of delivery using cationic lipids and helper lipids
US5958894A (en) * 1997-04-04 1999-09-28 Megabios Corporation Amphiphilic biguanide derivatives
US5948925A (en) * 1997-05-06 1999-09-07 Genzyme Corporation Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
US5952516A (en) * 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
US5942634A (en) * 1997-05-09 1999-08-24 Genzyme Corporation Cationic amphiphiles for cell transfections
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
CA2641217A1 (en) 1997-11-20 1999-06-03 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
GB0413613D0 (en) * 2004-06-17 2004-07-21 Univ London Small molecule carriers
US9301980B2 (en) 2013-07-16 2016-04-05 The Board Of Trustees Of The Leland Stanford Junio Enhancement of osteogenic potential of bone grafts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules

Also Published As

Publication number Publication date
EP0730405A4 (en) 1997-02-19
AU691226B2 (en) 1998-05-14
CA2176715A1 (en) 1995-06-01
NZ276975A (en) 1998-04-27
KR960705771A (ko) 1996-11-08
EP0730405A1 (en) 1996-09-11
AU1184295A (en) 1995-06-13
JPH09505808A (ja) 1997-06-10
WO1995014381A1 (en) 1995-06-01
NO962074L (no) 1996-07-11

Similar Documents

Publication Publication Date Title
NO962074D0 (no) Amfifiliske derivater av guanidin
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DE69429359D1 (de) Orale zubereitungen von antimykotika
FI940574A0 (fi) Bentseenisulfonamidijohdannaiset herbisideinä
DK0551048T3 (da) 2-Imidazon-5-on- og 2-imidazolin-5-thion-derivater som fungicider
DE69429147D1 (de) Benzamidderivate
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
DE69603269D1 (de) Derivate von inulin
DE69329894D1 (de) Arylamidderivate
FI934519A0 (fi) Foerfarande foer finfoerdelning av inmatat material vid en kvackningsprocess med flytbaeddskatalysator
NO950477D0 (no) Aminosyrederivater
FI953021A0 (fi) 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä
DE69514284D1 (de) Herstellung von Catechol-Estrogen-Derivaten
FI950486A (fi) Amidijohdannaiset
NO980009L (no) Triazolin og isokazolin bis-oksim derivater og deres anvendelse som pesticider
FI932350A (fi) Foerfarande foer separering av katalysatorfri arbetsloesning ur hydreringskretsloppet vid framstaellning av vaeteperoxid med antrakinonfoerfarandet
FI944280A0 (fi) Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
TR199600067A2 (tr) 4-merkapto-benzoil guanidin türevleri.
NO931399D0 (no) Anvendelse av naturstein
NO921907D0 (no) Anvendelse av pyridinylpyrimidinderivater for beskyttelseav tekniske materialer
DK0675681T3 (da) Arylamino-alkoiminoderivater og deres anvendelse som fungicider
NO923808D0 (no) Substituert sulfonamidderivat og farmasoeytisk formuleringinneholdende det samme
FI940309A (fi) 6-kloori-5-fluori-3-(2-tenoyyli)-2-oksindoli-1-karboksamidin lysiinisuola
FR2682944B1 (fr) Nouveau compose aluminophosphate et ses derives.
FI953518A0 (fi) Uudet substituoidut tiosemikarbatsonijohdannaiset